CHICAGO, June 06, 2019 (GLOBE NEWSWIRE) — Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug…Original Article
Xeris Pharmaceuticals Receives Notification of PDUFA Date Extension for Gvoke
